ALKERMES | ALKS - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 384.69B 19.14B 2026-03
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
ALKERMES USD 5.88B 1.26B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 11.91B 11.05B 2026-06
Neurocrine Biosciences USD 13.25B 890M 2026-03
Otsuka Holdings JPY 5.98T 1.16T 2026-03
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pfizer USD 153.81B 12.24B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03